In the spring, the U.S. government and the World Health Organization declared an end to the COVID-19 global health emergency.
Novel dual-target CAR T cell therapy shows promise in treating recurrent glioblastoma
Targeting two brain tumor-associated proteins-;rather than one-;with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent